NCT06171789 2026-02-25PRO1107 in Patients With Advanced Solid TumorsGenmabPhase 1/2 Terminated33 enrolled
NCT06625515 2026-02-24First-in-Human Study of ATX-559, an Oral Inhibitor of DHX9, in Patients With Advanced or Metastatic Solid Tumors, and Molecularly Defined CancersAccent TherapeuticsPhase 1 Terminated17 enrolled
NCT06457997 2026-01-29A Study of PHN-010 in Patients With Advanced Solid TumorsPheon TherapeuticsPhase 1 Terminated26 enrolled
NCT05082025 2026-01-09Phase 2 Study of PI3K Inhibitor Copanlisib in Combination With Fulvestrant in Selected ER+ and/or PR+ Cancers With PI3K (PIK3CA, PIK3R1) and/or PTEN AlterationsM.D. Anderson Cancer CenterPhase 2 Terminated7 enrolled 10 charts
NCT05194072 2026-01-09A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid TumorsSeagen Inc.Phase 1 Terminated250 enrolled
NCT03746431 2026-01-07A Phase 1 Study of [225Ac]-FPI-1434 InjectionFusion Pharmaceuticals Inc.Phase 1 Terminated78 enrolled